This investigation has raised concerns about potential legal and reputational ... the approval process for Pfizer’s vaccine candidates. Despite these challenges, Pfizer maintains a Moderate ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Smith’s activist challenge got off to a shambolic ... Smith then accused Pfizer of threatening the pair with legal action to get the former executives to change their tune.

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE ... rebounded after Wall Street analysts highlighted the significant legal challenges the order would face. The pharmaceutical industry has ...

Pfizer's historical legal issues and lobbying activities could lead to RICO charges if RFK Jr. uncovers evidence of fraudulent practices. Despite potential risks, Pfizer's low P/E ratio and robust ...

Pfizer defended the initiative ... this complaint fits a larger wave of legal challenges to diversity programs.

Kobach, a Republican, is launching the legal challenge as the pandemic has begun ... making that decision receive the truth,” he said. Pfizer made misrepresentations of a “safe and effective ...

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

Despite facing legal challenges and investor pressure, such as litigation related to Oxbryta and interactions with activist investor Starboard, Pfizer has remained resilient. Its strategic ...